Contact
146 rue Léo Saignat
33000 Bordeaux
France
Chargé Relations Industrielles
About us
The ENSTBB aims to train, through FISE or FISA and continuous training programs, engineers specialized in the field of Biotherapies/Biologigs capable of assuming high-stakes roles for companies, people, and society while respecting the environment and striving for equal opportunities.
Since 2010, ENSTBB has also been offering a range of continuing education programs, both accredited and certified, in biotechnologies and bioproduction (products, processes, and controls), tailored to meet the needs of employees across the pharmaceutical/biotech sector. ENSTBB's continuing education program specializes in designing and delivering courses on therapeutic products derived from living organisms (such as proteins, antibodies, gene therapies, cell therapies, mRNA, etc.), their bioproduction processes, and quality control.
ENSTBB has a transfer center (BioTC-NA) whose objective is to offer companies innovative bioprocesses in the very early stages that can be industrialized.
Production, purification and characterization of biomolecules (Process development)
Business offer
Obtaining the engineering degree from ENSTBB through the validation of prior experiential learning (VAE).
The programs are to precisely address the skill development needs of personnel currently employed or seeking employment within the pharmaceutical/biotech sector, encompassing various profiles and roles including technicians, engineers, pharmacists, managers, etc., operating within the fields of R&D, production, equipment design, quality assurance, and regulatory compliance.
Bioproduction (Mammalian and microbial ) cell culture - Biofilm
Upstream Process (Cell line development - Process developmen - Process optimisation)
Downstream Process (Process development - Process optimisation - Labscale & Pilot scale)
Characterization / Analytics ( Physicochemical analysis - immunochemistry)
Activities
- Training Center
- Other
- Target selection & validation
- Expression and pathway analysis of target
- quantification of target
- Assay development in in-vitro & in-vivo models
- Hit discovery
- Screening & Identification
- In-vitro & ex-vivo models
- Immunotherapy lead generation
- Pharmacology & Biological activity
- Mode of Action
- Immunotherapy lead optimization
- Proof of concept
- Pharmacology potency
- CMC
- Master Cell Bank
- Production
- Cell Line development
- Clone selection
- Characterization
- Storage
- Analytical development
- Cell Culture
- Media composition
- Bioreactor conditions
- Cell expansion
- Stirred tank reactors
- Bioproduction
- Batches production type
- Mammalian
- Yeast
- Bacterial
- GLP compliance
- Volume
- Preclinical / Tox
- USP (Scale-Up)
- Cell expansion
- Inoculation
- Low volume containers to Bioreactors
- DSP (Recovery)
- Harvest
- Filtration
- Purification
- Quality assurance, quality control & analytical process
- Stability Assessment
- Physical & chemical profile
- Shear/shaking
- Viscosity
- Photostability
- pH
- Freeze/thaw
- Heat/degradation
- Aggregation
- Cell line analytical development
- Host cell proteins
- Viral clearance
- Contaminants detection
